Solmetex, LLC, a leading provider of dental consumables and equipment based in Northborough, Massachusetts, announced the acquisition of ReLeaf on January 8, 2026. The deal expands Solmetex's portfolio into hands-free, high-volume evacuation technology for dental hygiene and clinical procedures.

What ReLeaf Does

ReLeaf's flagship product is a hands-free, high-volume evacuation system that simplifies three key procedural challenges simultaneously: evacuation, retraction, and dry-field maintenance. When placed in the patient's mouth, the device provides 280 degrees of suction, keeping the field dry during scaling, polishing, and restorative procedures without requiring an assistant to hold a suction tip.

The system addresses a persistent operational challenge in dental practices — the need for a second pair of hands during hygiene and restorative procedures. Dental hygienists performing scaling and root planing typically need an assistant for retraction and evacuation, or must constantly reposition handheld suction between instrument strokes. ReLeaf eliminates this compromise by providing continuous, hands-free high-volume evacuation.

The clinical advantages extend beyond convenience. Continuous high-volume evacuation during ultrasonic scaling significantly reduces aerosol generation — a concern that gained prominence during the COVID-19 pandemic and remains a focus of infection control protocols. Studies have shown that high-volume evacuation can reduce aerosol concentrations by up to 90% compared to saliva ejectors alone.

Strategic Rationale

For Solmetex, the acquisition strengthens its position as a category leader in patient safety and procedural efficiency. The company is known primarily for its amalgam separators (required by EPA regulation since 2020) and infection control products. Adding ReLeaf extends the portfolio into active procedural support equipment, creating a more comprehensive offering for infection control and workflow optimization.

The acquisition targets both independent practices and Dental Service Organizations (DSOs), where standardized equipment procurement and operational efficiency are key priorities. DSOs in particular benefit from products that reduce staffing requirements per operatory — a critical metric given ongoing dental assistant shortages across North America and Europe.

Market Context

The dental hygiene equipment segment is seeing increased investment as practices look to optimize workflows with fewer support staff. Labor shortages in dental assisting have driven demand for products that reduce the need for chairside assistance. According to the American Dental Association, dental assistant vacancy rates remain elevated at approximately 35% above pre-pandemic levels.

Products that enable single-operator dentistry — where one clinician can perform procedures without an assistant — are gaining traction. ReLeaf fits this trend by enabling hygienists and dentists to maintain a dry, visible operating field without a second person holding suction.

Financial Terms

Financial terms of the transaction were not disclosed. The acquisition was funded from Solmetex's existing resources, suggesting the company viewed the deal as immediately accretive to its product portfolio.

Relevance for CEE

While Solmetex and ReLeaf are primarily US-focused brands, the underlying trend — hands-free procedural tools that reduce staffing requirements — is globally relevant. European dental practices face similar staffing challenges, particularly in CEE countries where dental assistant training programs are limited. Distributors of dental hygiene equipment in Poland, Czech Republic, and other CEE markets should monitor potential distribution partnerships as Solmetex expands internationally.

The aerosol reduction capability is also relevant for European practices implementing updated infection control guidelines from national dental associations.

FAQ

What is ReLeaf? A hands-free, high-volume evacuation system that provides 280 degrees of suction for dry-field maintenance during dental procedures without requiring an assistant.

Why is this acquisition significant? It expands Solmetex from infection control consumables into active procedural equipment, addressing the dental staffing shortage by enabling single-operator workflows.

Is ReLeaf available in Europe? Currently US-focused. Monitor Solmetex's international distribution announcements for European availability.


Source: Solmetex Press Release